skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
Whilst many market observers predicted a reduction in investor appetites for life science initial public offerings at the end of 2015, investors continued to support life sciences IPOs globally in 2016. What really set 2016 apart from previous years was both the global diversity of the offerings – the US was no longer as dominant as it once was for biotech IPOs – and the fact that the top three offerings accounted for more than two thirds of the total sums raised.

Download Your Report Today And Discover

 

• Monthly Healthcare and Biotech Fund Flows Versus Performance Since 2014

• Daily Healthcare and Biotech Fund Flows (July 1, 2016 – October 16, 2016)

• Top 10 Fundraisers Get Mix Of Venture, Corporate Support

• Strategic Investing Versus Investing For A Portfolio

• And much more

 

Find out more about how pharma, biotech and medtech can raise capital in 2017. Download your complimentary report from Pharma Intelligence Informa and EBD Group today

BST

Read also

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: